FEATURED
Tirzepatide (GIP/GLP-1)
Dual GIP/GLP-1 receptor agonist studied for metabolic regulation.
For research use only. Not for human consumption.
Delivery & Storage
Shipped as a ready-to-use liquid solution. Refrigerate promptly after delivery and follow the storage guidance on the batch documentation.
Keep refrigerated at 2–8 °C after delivery. Protect from heat and follow the batch-specific storage guidance.
Use aseptic handling and keep the vial closed when not in use. Do not add water or other solvents unless your approved research protocol requires it.
Return to refrigerated storage promptly. Protect from light, avoid repeated freeze-thaw cycles, and discard if cloudy or particulate.
Certificate of Analysis
Every batch is independently third-party tested for identity and purity. Published certificates and our batch disclosure policy live in one central place.
View certificates of analysisReviews
Molecular Specifications
| Compound Name | Tirzepatide (GIP/GLP-1) |
| CAS Number | 2023788-19-2 |
| Formula | C225H348N48O68 |
| Weight | 4813.45 g/mol |
| Sequence | Tyr-Aib-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(γGlu-(AEEA)2-C20 diacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
Description
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Research investigates its effects on glucose metabolism and body composition. Supplied as a liquid solution for laboratory use.